Aandeel WELCURE6 WELCURE DRUGS & PHARMACEUTICALS LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Welcure Drugs & Pharmaceuticals Limited

Aandelen

WELCURE6

INE331C01017

Beurs gesloten - Bombay S.E.
Andere beurzen
 12:00:52 17-05-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
5,15 INR +4,89% Intraday-grafiek van Welcure Drugs & Pharmaceuticals Limited +7,29% +33,77%
22/03 Welcure Drugs & Pharmaceuticals Limited kondigt het ontslag aan van Priti Rajesh Kharwar als bijkomend bestuurder, met ingang van 28 maart 2024 CI
15/02 Welcure Drugs & Pharmaceuticals Limited kondigt ontslag van de Raad van Bestuur aan CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Welcure Drugs & Pharmaceuticals Limited Announces the Resignation of Priti Rajesh Kharwar as Additional Director, Effective from March 28, 2024
Welcure Drugs & Pharmaceuticals Appoints Managing Director, CFO
Welcure Drugs & Pharmaceuticals Limited Announces Board Resignations
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Vishal Mehra as Chief Financial Officer
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mr. Vishal Mehra as Managing Director
Welcure Drugs & Pharmaceuticals Limited Approves Executive Changes
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Managing Director
Welcure Drugs & Pharmaceuticals Limited Approves Appointment of Altaf Hussain Shah as Chief Financial Officer
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Welcure Drugs & Pharmaceuticals Limited Approves the Shifting of the Registered Office
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Welcure Drugs & Pharmaceuticals Limited Announces Change of Address
Welcure Drugs & Pharmaceuticals Limited Approves Board Changes
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mayank Bhandari as Non Executive and Independent Director
Welcure Drugs & Pharmaceuticals Limited Announces Executive Changes
Welcure Drugs & Pharmaceuticals Limited Approves Shifting of Registered Office Within the Local Limits of City of Delhi
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023
Welcure Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Welcure Drugs & Pharmaceuticals Limited Announces Resignation of Mitashi Bisaria as Company Secretary / Compliance Officer, Effective October 8, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers WELCURE6
  4. Nieuws Welcure Drugs & Pharmaceuticals Limited
  5. Andere talen